These data have implications that DSS exhibits a renoprotective effect in an animal model of diabetic nephropathy by inhibiting the expression of TGF-β1, which might be linked to its beneficial effect on the hyperglycemic state but did not correlate with blocking intrarenal renin angiotensin system. This evidence concerns the gene TGFB1 and diabetic kidney disease.